JXFG.F Stock Overview
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Jinxin Fertility Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.20 |
52 Week High | HK$0.50 |
52 Week Low | HK$0.20 |
Beta | 1.4 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -92.41% |
Recent News & Updates
Recent updates
Shareholder Returns
JXFG.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 2.6% | 0.6% |
1Y | n/a | 4.4% | 25.7% |
Return vs Industry: Insufficient data to determine how JXFG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how JXFG.F performed against the US Market.
Price Volatility
JXFG.F volatility | |
---|---|
JXFG.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: JXFG.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine JXFG.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1951 | 3,273 | Yang Dong | www.jxr-fertility.com |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Jinxin Fertility Group Limited Fundamentals Summary
JXFG.F fundamental statistics | |
---|---|
Market cap | US$1.07b |
Earnings (TTM) | US$47.70m |
Revenue (TTM) | US$385.93m |
22.4x
P/E Ratio2.8x
P/S RatioIs JXFG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
JXFG.F income statement (TTM) | |
---|---|
Revenue | CN¥2.79b |
Cost of Revenue | CN¥1.61b |
Gross Profit | CN¥1.18b |
Other Expenses | CN¥830.72m |
Earnings | CN¥344.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.13 |
Gross Margin | 42.15% |
Net Profit Margin | 12.36% |
Debt/Equity Ratio | 23.2% |
How did JXFG.F perform over the long term?
See historical performance and comparison